Search Within

Wei-Chu Victoria Lai

Formats
  1. Meeting Abstract (33)
  2. Journal Article (24)
  3. Editorial (2)
Groups
  1. Department of Medicine (59)
  2. Solid Tumor Oncology Division (59)
  3. Thoracic Oncology (59)
  4. GSK Faculty (40)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (36)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (36)

More Groups

People
  1. Charles Rudin (34)
  2. Natasha Rekhtman (20)
  3. Jacklynn Egger (17)
  4. Alexander Drilon (15)
  5. Bob Li (15)
  6. Mark Kris (15)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (11)
  5. 2021 (14)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Journal of Thoracic Oncology (11)
  3. Modern Pathology (6)
  4. Laboratory Investigation (5)
  5. Annals of Oncology (3)
  6. Clinical Cancer Research (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. Elsevier Inc. (15)
  3. Nature Publishing Group (8)
  4. Nature Research (6)
  5. American Association for Cancer Research (4)
  6. Oxford University Press (3)

More Publishers

Results (59)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 trial of sapanisertib and telaglenastat (CB-839) in patients with advanced NSCLC (NCI 10327): Results from dose escalation
    Meeting Abstract

    Riess, J.; Frankel, P.; Massarelli, E.; Nieva, J.; Lai, W. C. V.; Koczywas, M.; Shackelford, D.; Lanza, I.; Reid, J. M.; Gonsalves, W. I.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Phase 1 updated exploration and first expansion data for DLL3-targeted T-cell engager tarlatamab in small cell lung cancer
    Meeting Abstract

    Borghaei, H.; Paz-Ares, L.; Johnson, M.; Champiat, S.; Owonikoko, T.; Lai, V.; Boyer, M.; Hummel, H. D.; Govindan, R.; Steeghs, N.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • POU2F3 in SCLC: Clinicopathologic and genomic analysis with a focus on its diagnostic utility in neuroendocrine-low SCLC
    Journal Article

    Baine, M. K.; Febres-Aldana, C. A.; Chang, J. C.; Jungbluth, A. A.; Sethi, S.; Antonescu, C. R.; Travis, W. D.; Hsieh, M. S.; Roh, M. S.; Homer, R. J.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Rationale and design of the phase 3 KEYLYNK-013 study of pembrolizumab with concurrent chemoradiotherapy followed by pembrolizumab with or without olaparib for limited-stage small-cell lung cancer
    Journal Article

    Rimner, A.; Lai, W. C. V.; Califano, R.; Jabbour, S. K.; Rudin, C. M.; Faivre-Finn, C.; Cho, B. C.; Kato, T.; Yu, J.; Chafin, W.; more...
    Clinical Lung Cancer (2022)

    Fulltext@MSK | Save
  • Retinoblastoma (Rb) protein in small cell lung carcinoma: Combined genomic and immunohistochemical analysis with a description of a rare Rb-proficient subset
    Meeting Abstract

    Febres-Aldana, C.; Baine, M.; Chang, J.; Ptashkin, R.; Gedvilaite, E.; Ventura, K.; Bodd, F.; Egger, J.; Travis, W.; Lai, W. C.; more...
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Retinoblastoma (Rb) protein in small cell lung carcinoma: Combined genomic and immunohistochemical analysis with a description of a rare Rb-proficient subset
    Meeting Abstract

    Febres-Aldana, C.; Baine, M.; Chang, J.; Ptashkin, R.; Gedvilaite, E.; Ventura, K.; Bodd, F.; Egger, J.; Travis, W.; Lai, W. C.; more...
    Laboratory Investigation (2022)

    Fulltext@MSK | Save
  • Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts
    Journal Article

    Caeser, R.; Egger, J. V.; Chavan, S.; Socci, N. D.; Byrne Jones, C.; Kombak, F. E.; Asher, M.; Roehrl, M. H.; Shah, N. S.; Allaj, V.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • KEYNOTE-B98: Phase Ib/II study of pembrolizumab plus investigational agents as second-line treatment for anti-PD-1/PD-L1-refractory extensive-stage small cell lung cancer (ES-SCLC)
    Meeting Abstract

    Lai, W. C. V.; Ahn, M. J.; Shentzer, T.; Kowalski, D.; Cho, B. C.; Schmid, S.; JoveĢ, M.; Huang, M.; Zhao, B.; El-Osta, H.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Signatures of plasticity and immunosuppression in a single-cell atlas of human small cell lung cancer
    Meeting Abstract

    Chan, J.; Quintanal-Villalonga, A.; Gao, V.; Xie, Y.; Allaj, V.; Chaudhary, O.; Masilionis, I.; Egger, J.; Chow, A.; Walle, T.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • KEYLYNK-013: A phase 3 study of pembrolizumab in combination with concurrent chemoradiation therapy followed by pembrolizumab with or without olaparib versus concurrent chemoradiation therapy in patients with newly diagnosed limited-stage SCLC
    Meeting Abstract

    Rimner, A.; Lai, W. V. V.; Califano, R.; Jabbour, S. K.; Faivre-Finn, C.; Cho, B. C.; Kato, T.; Yu, J.; Yu, L.; Zhao, B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save